share_log

UMB Bank N.a. Acquires 466 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

UMB Bank N.a. Acquires 466 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

UMB Bank N.A.收购直觉外科公司股份有限公司(纳斯达克代码:ISRG)466股
Defense World ·  2022/10/02 08:32

UMB Bank n.a. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,208 shares of the medical equipment provider's stock after purchasing an additional 466 shares during the period. UMB Bank n.a.'s holdings in Intuitive Surgical were worth $2,049,000 at the end of the most recent reporting period.

UMB Bank n.a.根据纳斯达克向美国证券交易委员会披露的最新信息,其在第二季度增持了美国证券交易委员会公司的股票4.8%。该基金在此期间额外购买了466股后,拥有这家医疗设备提供商的10,208股股票。在最近一个报告期结束时,联合信贷银行持有的直觉外科公司股份价值2,049,000美元。

Several other large investors also recently made changes to their positions in ISRG. Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Intuitive Surgical by 7.9% during the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider's stock valued at $205,000 after acquiring an additional 50 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Intuitive Surgical by 0.9% during the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider's stock valued at $133,012,000 after acquiring an additional 3,982 shares during the period. MCIA Inc lifted its stake in shares of Intuitive Surgical by 5.6% during the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider's stock valued at $1,003,000 after acquiring an additional 190 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Intuitive Surgical by 2.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,616 shares of the medical equipment provider's stock valued at $7,550,000 after acquiring an additional 952 shares during the period. Finally, Raymond James Financial Services Advisors Inc. lifted its stake in shares of Intuitive Surgical by 0.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 88,814 shares of the medical equipment provider's stock valued at $26,793,000 after acquiring an additional 578 shares during the period. Institutional investors own 82.44% of the company's stock.

其他几家大型投资者最近也改变了他们在ISRG的头寸。今年第一季度,Mitchell McLeod Pugh&Williams Inc.增持的直觉外科公司股份增加了7.9%。Mitchell McLeod Pugh&Williams Inc.在此期间增持了50股,目前持有这家医疗设备提供商679股股票,价值20.5万美元。今年第一季度,安维斯特资产管理公司增持的直觉外科公司股份增加了0.9%。Envestnet Asset Management Inc.在此期间额外收购了3982股,现在拥有440,904股这家医疗设备提供商的股票,价值133,012,000美元。今年第一季度,MCIA Inc.增持了5.6%的直觉外科公司股份。MCIA Inc.目前拥有这家医疗设备提供商3,596股股票,价值1,003,000美元,在此期间又购买了190股。三井住友DS资产管理有限公司在第二季度增持了2.6%的直觉外科公司股份。三井住友DS资产管理有限公司在此期间额外收购了952股,现在拥有这家医疗设备提供商37,616股股票,价值7,550,000美元。最后,雷蒙德·詹姆斯金融服务顾问公司(Raymond James Financial Services Advisors Inc.)在第一季度将直觉外科公司的持股比例提高了0.7%。雷蒙德·詹姆斯金融服务顾问公司(Raymond James Financial Services Advisors Inc.)目前持有这家医疗设备提供商88,814股股票,价值26,793,000美元,在此期间又购买了578股。机构投资者持有该公司82.44%的股票。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Intuitive Surgical Stock Performance

直觉外科公司股票表现

NASDAQ:ISRG opened at $187.44 on Friday. The company has a market cap of $66.94 billion, a PE ratio of 47.69, a PEG ratio of 5.26 and a beta of 1.31. Intuitive Surgical, Inc. has a 52-week low of $184.94 and a 52-week high of $369.69. The stock has a 50-day simple moving average of $216.24 and a 200 day simple moving average of $229.94.

纳斯达克:ISRG上周五开盘报187.44美元。该公司市值为669.4亿美元,市盈率为47.69倍,聚乙二醇率为5.26倍,贝塔系数为1.31。直觉外科公司的股价为184.94美元,为52周低点,52周高点为369.69美元。该股的50日简单移动均线切入位为216.24美元,200日简单移动均线切入位为229.94美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the previous year, the business posted $1.42 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current fiscal year.
直觉外科公司(纳斯达克代码:ISRG-GET Rating)上一次发布季度收益数据是在7月21日星期四。这家医疗设备供应商公布本季度每股收益(EPS)为0.85美元,低于分析师普遍预期的1.04美元(0.19美元)。该公司本季度营收为15.2亿美元,而市场普遍预期为15.6亿美元。直觉外科公司的股本回报率为12.04%,净利润率为24.05%。在去年同期,该业务公布的每股收益为1.42美元。研究分析师平均预测,直觉外科公司公司本财年每股收益将达到3.76欧元。

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

Several brokerages have recently issued reports on ISRG. Truist Financial cut their price target on Intuitive Surgical from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, July 22nd. Raymond James cut their target price on Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Evercore ISI cut their target price on Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Morgan Stanley cut their target price on Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a research note on Friday, July 15th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Intuitive Surgical from $225.00 to $205.00 in a research note on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $268.00.

几家券商最近发布了关于ISRG的报告。7月22日,Truist Financial将直觉外科公司的目标价从270.00美元下调至255.00美元,并在一份研究报告中对该股设定了“买入”评级。雷蒙德·詹姆斯在7月22日星期五的一份研究报告中将直觉外科公司的目标价从294.00美元下调至255.00美元。7月22日,周五,Evercore ISI在一份研究报告中将直觉外科公司的目标价从210.00美元下调至175.00美元。7月15日,摩根士丹利在一份研究报告中将直觉外科公司的目标价从300.00美元下调至225.00美元,并对该股设定了“同等权重”的评级。最后,德意志银行在7月22日星期五的一份研究报告中将直觉外科公司的目标价从225.00美元下调至205.00美元。6名股票研究分析师对该股的评级为持有,12名分析师对该股的评级为买入。根据MarketBeat.com的数据,该公司目前的共识评级为“适度买入”,共识目标价为268.00美元。

Insider Buying and Selling

内幕买卖

In related news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 9,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 79,412 shares of the firm's stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the transaction, the chief executive officer now owns 54,607 shares of the company's stock, valued at $11,811,494.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 101,162 shares of company stock worth $22,062,916. 0.90% of the stock is owned by corporate insiders.

在相关新闻中,执行副总裁Myriam Curet在7月27日星期三的交易中出售了9000股该股。股票以225.00美元的平均价格出售,总成交金额为2,025,000.00美元。交易完成后,执行副总裁总裁现在直接持有该公司217股,价值48,825美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过这个环节。在直觉外科公司的另一则消息中,执行副总裁米里亚姆·库雷特在7月27日(星期三)的一笔交易中出售了9000股该公司的股票。这只股票的平均售价为225.00美元,总价值为2,025,000.00美元。交易完成后,执行副总裁总裁现在直接持有该公司217股,价值48,825美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。此外,在7月26日(星期二)的一次交易中,首席执行官加里·S·古萨特出售了79,412股公司股票。这些股票的平均价格为216.30美元,总价值为17,176,815.60美元。交易完成后,首席执行官现在拥有54,607股公司股票,价值11,811,494.10美元。关于这次销售的披露可以找到这里。在过去三个月里,内部人士出售了101,162股公司股票,价值22,062,916美元。0.90%的股份由企业内部人士持有。

Intuitive Surgical Company Profile

直觉外科公司公司简介

(Get Rating)

(获取评级)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

直觉外科公司公司开发、制造和营销产品,使医生和医疗保健提供者能够在美国和国际上提高微创护理的质量和获得微创护理的机会。该公司提供达芬奇外科系统,以实现使用微创方法进行复杂手术;以及离子腔内系统,将其商业产品从外科扩展到能够进行微创肺活组织检查的诊断程序。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • Let Paychex Stock Work Hard For You
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • 电动汽车电池制造商Freyr将在全球大举扩张
  • MarketBeat:回顾一周9/26-9/30
  • 这是买入美光科技的难忘时刻
  • 利润下降对CarMax价值主张的挑战
  • 让Paychex股票为您努力工作

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发